Microvascular coronary dysfunction and ischemic heart disease: where are we in 2014?
- PMID: 25454903
- PMCID: PMC4336803
- DOI: 10.1016/j.tcm.2014.09.013
Microvascular coronary dysfunction and ischemic heart disease: where are we in 2014?
Abstract
Many patients with angina and signs of myocardial ischemia on stress testing have no significant obstructive epicardial coronary disease. There are many potential coronary and non-coronary mechanisms for ischemia without obstructive epicardial coronary disease, and prominent among these is coronary microvascular and/or endothelial dysfunction. Patients with coronary microvascular and/or endothelial dysfunction are often at increased risk of adverse cardiovascular events, including ischemic events and heart failure despite preserved ventricular systolic function. In this article, we will review the diagnosis and treatment of coronary microvascular and endothelial dysfunction, discuss their potential contribution to heart failure with preserved ejection fraction, and highlight recent advances in the evaluation of atherosclerotic morphology in these patients, many of whom have non-obstructive epicardial disease.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
None.
Figures




Comment in
-
Seeing is believing: new updates on coronary microvascular dysfunction.Trends Cardiovasc Med. 2015 Feb;25(2):104-6. doi: 10.1016/j.tcm.2014.10.009. Epub 2014 Oct 19. Trends Cardiovasc Med. 2015. PMID: 25453987 No abstract available.
Similar articles
-
Ischemia and no obstructive coronary arteries (INOCA): A narrative review.Atherosclerosis. 2022 Dec;363:8-21. doi: 10.1016/j.atherosclerosis.2022.11.009. Epub 2022 Nov 12. Atherosclerosis. 2022. PMID: 36423427 Free PMC article. Review.
-
Coronary endothelial dysfunction in non-obstructive coronary artery disease: Risk, pathogenesis, diagnosis and therapy.Vasc Med. 2016 Apr;21(2):146-55. doi: 10.1177/1358863X15618268. Epub 2015 Dec 15. Vasc Med. 2016. PMID: 26675331 Review.
-
Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know.Curr Atheroscler Rep. 2023 Aug;25(8):435-446. doi: 10.1007/s11883-023-01116-z. Epub 2023 Jun 20. Curr Atheroscler Rep. 2023. PMID: 37338666 Free PMC article. Review.
-
Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study.Int J Cardiol. 2016 Nov 15;223:936-939. doi: 10.1016/j.ijcard.2016.07.301. Epub 2016 Aug 12. Int J Cardiol. 2016. PMID: 27589041 Free PMC article.
-
Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week.J Am Coll Cardiol. 2023 Feb 7;81(5):505-514. doi: 10.1016/j.jacc.2022.08.814. J Am Coll Cardiol. 2023. PMID: 36725179 Free PMC article. Review.
Cited by
-
The role of coronary microvascular disorder in congestive heart failure.Am J Physiol Heart Circ Physiol. 2015 Apr 15;308(8):H814-5. doi: 10.1152/ajpheart.00118.2015. Epub 2015 Feb 27. Am J Physiol Heart Circ Physiol. 2015. PMID: 25724488 Free PMC article. No abstract available.
-
Left ventricular ischemia in pre-capillary pulmonary hypertension: a cardiovascular magnetic resonance study.Cardiovasc Diagn Ther. 2020 Oct;10(5):1280-1292. doi: 10.21037/cdt-20-698. Cardiovasc Diagn Ther. 2020. PMID: 33224752 Free PMC article.
-
Advances in the diagnosis and management of post-percutaneous coronary intervention coronary microvascular dysfunction: Insights into pathophysiology and metabolic risk interactions.World J Cardiol. 2025 Feb 26;17(2):103950. doi: 10.4330/wjc.v17.i2.103950. World J Cardiol. 2025. PMID: 40061275 Free PMC article. Review.
-
Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.Heart Vessels. 2019 Mar;34(3):410-418. doi: 10.1007/s00380-018-1260-z. Epub 2018 Sep 18. Heart Vessels. 2019. PMID: 30229410
-
HuR/Cx40 downregulation causes coronary microvascular dysfunction in type 2 diabetes.JCI Insight. 2021 Nov 8;6(21):e147982. doi: 10.1172/jci.insight.147982. JCI Insight. 2021. PMID: 34747371 Free PMC article.
References
-
- Likoff W, Segal BL, Kasparian H. Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease. N Engl J Med. 1967;276:1063–6. - PubMed
-
- Kemp HG. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol. 1973;32:375–6. - PubMed
-
- Cannon RO, Epstein SE. “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988;61:1338–43. - PubMed
-
- Luke RG. Hypertensive nephrosclerosis: pathogenesis and prevalence. Essential hypertension is an important cause of end-stage renal disease. Nephrol Dial Transplant. 1999;14:2271–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical